GBT Technologies Inc (PK) (GTCH)

Wizzerdo...same could be said for $TWOH!! Show shareholders the money after 10 months of complete BULLSHIT dealing with the CSE!!!!!!!!!!

Israeli-based penny stocks on the OTC markets often experience explosive percentage gains when specific business milestones, such as successful FDA trial results or international enterprise contracts, are met. These equities trade with high volatility and are particularly sensitive to regulatory approvals and capital injections

.Notable examples of Israeli companies and their paths to value creation include:

1. Compugen Ltd. (NASDAQ/OTC: CGEN)The Business Plan: A clinical-stage cancer immunotherapy company focusing on predictive target discovery.The Catalyst & Gain: Compugen frequently trades at lower price valuations but has experienced massive rallies. For example, when its business model and preclinical data yielded high-profile partnership and licensing deals (such as their milestone agreement with Bristol Myers Squibb), the stock surged. Following major collaboration announcements, CGEN has historically ripped from under \(\$2\) to over \(\$10\) per share at different points in its developmental pipeline journey.

2. BioLineRx Ltd. (NASDAQ/OTC: BLRX)The Business Plan: A clinical-stage biopharmaceutical company focused on oncology.The Catalyst & Gain: BioLineRx has previously traded in the penny stock tier before hitting major milestones, such as the FDA approval and European commercial rollout of their stem-cell mobilization drug, Motixafortide (marketed as APHEXDA). When this clinical plan came to fruition, the stock experienced massive short-term boosts, often seeing double-digit to triple-digit percentage jumps on the news of NDA acceptances and subsequent commercial partnerships

.3. RedHill Biopharma Ltd. (OTC: RDHL)The Business Plan: A specialty biopharma company primarily focused on gastrointestinal and infectious diseases.The Catalyst & Gain: RedHill has utilized a strategy of acquiring, developing, and commercializing late-stage clinical assets. When their drugs (such as Talicia for H. pylori or Movantik for OIC) achieved FDA approval and were officially commercialized, the stock saw significant short squeezes and fundamental rallies, vaulting from micro-penny levels to over \(\$10\) (pre-reverse split figures) during their strongest commercial scaling periods.Key Risks & ConsiderationsCommunity discussions regarding Israeli OTC penny stocks generally warn of the extreme volatility involved. According to consensus on Reddit's Penny Stocks Board, many of these startups utilize warrant inducement and frequent offerings to finance their trials. The regulatory and reporting requirements for foreign micro-caps can also differ from strict U.S. domestic standards. Investors usually watch for highly specific catalysts like FDA meetings or exclusive distribution agreements rather than long-term value investing.


GTCH appears to be an Israeli based operation..Does anybody know any other OTC examples of Israeli based penny stocks and what they were able to achieve in terms of price gains when their business plans came together?

Yes, GBT Technologies Inc. (OTC: GTCH) has a direct connection to Israel, primarily through a strategic joint venture for defense and space technologies.GBT Technologies entered into a partnership and joint venture agreement with AIPHEX LTD, an Israel-based defense and technology company specializing in AI-driven sensing, autonomy, and navigation platforms. Together with other partners, they formed a Nevada-based limited liability company to develop "combat-proven" defense and space technologies. GBT contributed a portion of its intellectual property and equity to this joint venture.

From AI

-----------------------------------------------------------------------------------------------------------

GTCH appears to be an Israeli based operation..Does anybody know any other OTC examples of Israeli based penny stocks and what they were able to achieve in terms of price gains when their business plans came together?

That IMO is Good Company to have

GTCH appears to be an Israeli based operation..Does anybody know any other OTC examples of Israeli based penny stocks and what they were able to achieve in terms of price gains when their business plans came together?

GTCH appears to be an Israeli based operation..Does anybody know any other OTC examples of Israeli based penny stocks and what they were able to achieve in terms of price gains when their business plans came together?

"* Management has consistently stated that monetizing intellectual property is a core strategy through sales, licensing, and joint ventures."

Conservative estimate: $10–25 million.
* Moderate estimate: $25–50 million.
* Optimistic estimate: $50 million or more, but only if the company successfully commercializes or licenses its AI, wireless, imaging, and semiconductor technologies rather than simply holding the patents. This higher range is much more uncertain.

The reasons some investors assign meaningful value to the portfolio are:

* GTCH has already completed patent transactions, indicating that at least some of its IP has attracted buyer interest.
* The company has continued to report ownership of patents and patent applications focused on AI, networking, imaging, and semiconductor-related technologies.
* Management has consistently stated that monetizing intellectual property is a core strategy through sales, licensing, and joint ventures.

Yeah, when there's no bid it's pretty tough to do a sell.

Show the shareholders the money.
If GTCH can demonstrate one or more of the following:

* meaningful licensing revenue,
* profitable patent sales,
* successful commercialization of its technology,
* or sustained operating revenue,

GTCH still owns a portfolio of patents and patent applications, even after selling certain IP assets.
* The company has previously announced patent transactions with values in the tens of millions of dollars, suggesting that at least some of its intellectual property has commercial value.
* GTCH also owns an equity stake in VisionWave Holdings (VWAV), which could become more valuable if that company grows.

Conservative estimate: $10–25 million.
* Moderate estimate: $25–50 million.
* Optimistic estimate: $50 million or more, but only if the company successfully commercializes or licenses its AI, wireless, imaging, and semiconductor technologies rather than simply holding the patents. This higher range is much more uncertain.

The reasons some investors assign meaningful value to the portfolio are:

* GTCH has already completed patent transactions, indicating that at least some of its IP has attracted buyer interest.
* The company has continued to report ownership of patents and patent applications focused on AI, networking, imaging, and semiconductor-related technologies.
* Management has consistently stated that monetizing intellectual property is a core strategy through sales, licensing, and joint ventures.

* In August 2023, GBT announced an agreement for Bannix Acquisition Corp. to acquire the Apollo IP system, consisting of 4 granted patents and 1 pending patent, for a stated value of $42.5 million, to be paid in preferred stock.
* GBT also disclosed that it had completed two IP sales to third parties while continuing to build and expand its remaining intellectual property portfolio. After those transactions, the company stated it still held 18 patents and 26 pending patent applications through GBT Tokenize.

No bid and definitely a RS coming, ask Porch.

After the holidays I promise no Reverse Split which will make that right at 971 days.. that idea was abandoned and counting. 18 and approximately 1/2 in dog Years. Can anyone confirm that math..do we have a computer Bott running around in here that confirm that?

After the Holiday , I promise no bid next week.

Yes, You are right! After the holiday!

There is no Wertheim

Joe Botts, Wertheim after the holiday! Cheers!

Yes, it's the only video that won't load up with sound, I'll try later, gl.

It's a video from Facebook. Is your Facebook account open?

Buy: 21,230,000 Neutral: 34,000 Sell: 1,000,000

I can't get it to play, figures.

Unfortunately Clarity Act chances diminish daily.

Facebook's for fools.

https://kalshi.com/markets/kxcryptostructure/crypto-market-structure/kxcryptostructure-26jan

I would like to believe that, yet I have not seen a coherent explanation why the stock price does not reflect it. Why is it no bid/selling for the retail minimum price then?

Not so loudly please

GTCH has more value than most folks think.

Lol.. sure some guy on FB , maybe it goes to No bid 0.0001.

Saw this today. What do you think? I heard months ago several monetary related changes were going to be announced on the 4th. If it does it would add great value to gtch and what we're anticipating based on recent developments and the proposed new company.

https://www.facebook.com/share/r/18omWvp5mA/

As per finra daily short sale VOLUME (NOT SHORT INTEREST) files, 34% short sale VOLUME (NOT SHORT INTEREST) today. 20260701|GTCH|7592243|0|22289510

Right not really a fan of the cashless society part but hey when in Rome as they, might as well leverage, what we're waiting for out of it is TOKENIZATION as in GBT tokenize, check out those patents, got some bangers... woooweee LFG, the wait will be worth it. There's a convergence happening.

The Clarity Act is an important piece of the move to a digital no cash monetary system. It's my understanding the hold up is related to how and who can offer interest on these fully digital assets. My gut says it gets passed sooner than later. Maybe by this summer but hopefully this fall or no later than early 2027 after the new Congress members are sworn in.

And still NO BID.... LMAO

Buy: 18,560,949 Neutral: 3,728,561 Sell: 0

The Digital Asset Market Clarity Act (H.R. 3633) is currently sitting on the Senate Legislative Calendar under General Orders (Calendar No. 423).The legislation is stalled behind closed doors as the Senate observes its July 4 holiday recess.Current Status and Next StepsSenate Floor Schedule: Lawmakers will return to Washington on July 13, 2026. Proponents are pushing for a full floor vote before the August summer recess, but the schedule is heavily crowded with must-pass defense bills like the National Defense Authorization Act (NDAA).Draft Revision: Senator Cynthia Lummis indicated that an updated compromise draft will be released in early July 2026 for a final round of public feedback before leadership attempts to bring it to the floor.Falling Expectations: Due to the tight legislative timeline and escalating political gridlock, market analysts at firms like Galaxy Research and Jefferies have slashed the bill's odds of passing in 2026 to a 50-50 toss-up.If the Senate fails to act on the bill before the end of the summer, sponsor timelines suggest the framework could be delayed until 2027 or later.

Thank you! Lmao.

I'm an official gtch long now 😁
A year ago this week I met gtch and started buying and haven't stopped yet 😉

So is all ya others, lol.

Lmao... its no bid.

Well simplifying everything and only dealing with one government can't hurt right. I just think they been delaying deliberately to time to other things like vwav and new systems coming into place etc...

Interim ceo term is up 7-15

Poor Joe! How you doing today Sir.? Watch what happens. The Indian connection is coming. You heard it here first.

How does Two Hands dropping off the Canadian Exchange a week from today help them and GBT do you think?

Recent findings make it look like it's finally coming together.

Why not for much longer?

Of course not, after the RS, then back to no bid.

No for much longer foo lol

No bid as usual